These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 10865974)

  • 1. Combined effects of aberrant MEK1 activity and BCL2 overexpression on relieving the cytokine dependency of human and murine hematopoietic cells.
    Blalock WL; Moye PW; Chang F; Pearce M; Steelman LS; McMahon M; McCubrey JA
    Leukemia; 2000 Jun; 14(6):1080-96. PubMed ID: 10865974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergy between Raf and BCL2 in abrogating the cytokine dependency of hematopoietic cells.
    Moye PW; Blalock WL; Hoyle PE; Chang F; Franklin RA; Weinstein-Oppenheimer C; Pearce M; Steelman L; McMahon M; McCubrey JA
    Leukemia; 2000 Jun; 14(6):1060-79. PubMed ID: 10865973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of inducible MEK1 activation on the cytokine dependency of lymphoid cells.
    Blalock WL; Pearce M; Chang F; Lee JT; Pohnert SC; Burrows C; Steelman LS; Franklin RA; McMahon M; McCubrey JA
    Leukemia; 2001 May; 15(5):794-807. PubMed ID: 11368441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A conditionally-active form of MEK1 results in autocrine tranformation of human and mouse hematopoietic cells.
    Blalock WL; Pearce M; Steelman LS; Franklin RA; McCarthy SA; Cherwinski H; McMahon M; McCubrey JA
    Oncogene; 2000 Jan; 19(4):526-36. PubMed ID: 10698522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential abilities of the Raf family of protein kinases to abrogate cytokine dependency and prevent apoptosis in murine hematopoietic cells by a MEK1-dependent mechanism.
    Hoyle PE; Moye PW; Steelman LS; Blalock WL; Franklin RA; Pearce M; Cherwinski H; Bosch E; McMahon M; McCubrey JA
    Leukemia; 2000 Apr; 14(4):642-56. PubMed ID: 10764150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ability of the activated PI3K/Akt oncoproteins to synergize with MEK1 and induce cell cycle progression and abrogate the cytokine-dependence of hematopoietic cells.
    Shelton JG; Blalock WL; White ER; Steelman LS; McCubrey JA
    Cell Cycle; 2004 Apr; 3(4):503-12. PubMed ID: 15004527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential abilities of activated Raf oncoproteins to abrogate cytokine dependency, prevent apoptosis and induce autocrine growth factor synthesis in human hematopoietic cells.
    McCubrey JA; Steelman LS; Hoyle PE; Blalock WL; Weinstein-Oppenheimer C; Franklin RA; Cherwinski H; Bosch E; McMahon M
    Leukemia; 1998 Dec; 12(12):1903-29. PubMed ID: 9844921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Requirement for the PI3K/Akt pathway in MEK1-mediated growth and prevention of apoptosis: identification of an Achilles heel in leukemia.
    Blalock WL; Navolanic PM; Steelman LS; Shelton JG; Moye PW; Lee JT; Franklin RA; Mirza A; McMahon M; White MK; McCubrey JA
    Leukemia; 2003 Jun; 17(6):1058-67. PubMed ID: 12764369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of deregulated Raf activation on integrin, cytokine-receptor expression and the induction of apoptosis in hematopoietic cells.
    Weinstein-Oppenheimer C; Steelman LS; Algate PA; Blalock WL; Burrows C; Hoyle PE; Lee JT; Moye PW; Shelton JG; Franklin R; McCubrey JA
    Leukemia; 2000 Nov; 14(11):1921-38. PubMed ID: 11069028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of kinase cascade inhibitors on neoplastic and cytokine-mediated cell proliferation.
    Shelton JG; Moye PW; Steelman LS; Blalock WL; Lee JT; Franklin RA; McMahon M; McCubrey JA
    Leukemia; 2003 Sep; 17(9):1765-82. PubMed ID: 12970777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a conditional in vivo model to evaluate the efficacy of small molecule inhibitors for the treatment of Raf-transformed hematopoietic cells.
    Konopleva M; Shi Y; Steelman LS; Shelton JG; Munsell M; Marini F; McQueen T; Contractor R; McCubrey JA; Andreeff M
    Cancer Res; 2005 Nov; 65(21):9962-70. PubMed ID: 16267021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conditionally oncogenic forms of the A-Raf and B-Raf protein kinases display different biological and biochemical properties in NIH 3T3 cells.
    Pritchard CA; Samuels ML; Bosch E; McMahon M
    Mol Cell Biol; 1995 Nov; 15(11):6430-42. PubMed ID: 7565795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of factor-independent variants derived from TF-1 hematopoietic progenitor cells: the role of the Raf/MAP kinase pathway in the anti-apoptotic effect of GM-CSF.
    Chao JR; Chen CS; Wang TF; Tseng LH; Tsai JJ; Kuo ML; Yen JJ; Yang Yen HF
    Oncogene; 1997 Feb; 14(6):721-8. PubMed ID: 9038380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions between the PI3K and Raf signaling pathways can result in the transformation of hematopoietic cells.
    McCubrey JA; Lee JT; Steelman LS; Blalock WL; Moye PW; Chang F; Pearce M; Shelton JG; White MK; Franklin RA; Pohnert SC
    Cancer Detect Prev; 2001; 25(4):375-93. PubMed ID: 11531015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of Bcl2 phosphorylation and potential significance for leukemic cell chemoresistance.
    Deng X; Kornblau SM; Ruvolo PP; May WS
    J Natl Cancer Inst Monogr; 2001; (28):30-7. PubMed ID: 11158204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a conditionally active v-ErbB and an EGF-R inhibitor on transformation of NIH-3T3 cells and abrogation of cytokine dependency of hematopoietic cells.
    McCubrey JA; Shelton JG; Steelman LS; Franklin RA; Sreevalsan T; McMahon M
    Oncogene; 2004 Oct; 23(47):7810-20. PubMed ID: 15361836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An analysis of Mek1 signaling in cell proliferation and transformation.
    Greulich H; Erikson RL
    J Biol Chem; 1998 May; 273(21):13280-8. PubMed ID: 9582373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel point mutations in ERK2 that selectively disrupt binding to MEK1.
    Robinson FL; Whitehurst AW; Raman M; Cobb MH
    J Biol Chem; 2002 Apr; 277(17):14844-52. PubMed ID: 11823456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of Raf-1 and mitogen-activated protein kinase in murine macrophages partially mimics lipopolysaccharide-induced signaling events.
    Hambleton J; McMahon M; DeFranco AL
    J Exp Med; 1995 Jul; 182(1):147-54. PubMed ID: 7790814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the RAF/MEK/ERK and PI3K/AKT signal transduction pathways on the abrogation of cytokine-dependence and prevention of apoptosis in hematopoietic cells.
    Shelton JG; Steelman LS; Lee JT; Knapp SL; Blalock WL; Moye PW; Franklin RA; Pohnert SC; Mirza AM; McMahon M; McCubrey JA
    Oncogene; 2003 Apr; 22(16):2478-92. PubMed ID: 12717425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.